Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
J Intern Med ; 269(2): 160-71, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-20964739

RESUMO

OBJECTIVE: we evaluated the prognostic role of circulating cardiovascular biomarkers in patients with a history of recent atrial fibrillation (AF). BACKGROUND: predicting long-term maintenance of sinus rhythm in patients with AF is difficult. METHODS: plasma concentrations of three specific cardiac markers [high-sensitivity troponin T (hsTnT), N-terminal probrain natriuretic peptide (NT-proBNP) and mid-regional proatrial natriuretic peptide (MR-proANP)] and three stable fragments of vasoactive peptides [mid-regional proadrenomedullin (MR-proADM), copeptin (CT-proAVP) and CT-proendothelin-1 (CT-proET-1)] were measured at baseline and after 6 and 12 months in 382 patients enrolled in the GISSI-AF study, a prospective randomized trial to determine the effect of valsartan to reduce the recurrence of AF. The association between these markers, clinical characteristics and recurrence of AF was tested by univariate and multivariate Cox models. RESULTS: mean patient age was 68 ± 9 years (37.2% females). A total of 84.8% of patients had a history of hypertension. In total, 59.7% qualified for history of AF because of successful cardioversion, 11.8% because of two or more episodes of AF in the 6 months preceding randomization and 28.5% because of both. Patients in AF at 6 or 12 months (203 (53.1%) with first recurrence) had significantly higher concentrations of most biomarkers. Despite low baseline levels, higher concentrations of hsTnT {adjusted hazard ratio (HR) [95% confidence intervals (CIs) for 1 SD increment] (1.15 [1.04-1.28], P = 0.007), MR-proANP (1.15 [1.01-1.30], P = 0.04), NT-proBNP (1.24 [1.11-1.39], P = 0.0001) and CT-proET-1 (1.16 [1.01-1.33], P = 0.03) independently predicted higher risk of a first recurrence of AF. Changes over time of MR-proANP tended to predict subsequent recurrence (adjusted HR [95%CI]) (1.53 [0.98-2.37], P = 0.06). CONCLUSION: circulating markers of cardiomyocyte injury/strain and endothelin are related to recurrence of AF in patients in sinus rhythm with a history of recent AF.


Assuntos
Fibrilação Atrial/diagnóstico , Biomarcadores/sangue , Idoso , Bloqueadores do Receptor Tipo 1 de Angiotensina II/uso terapêutico , Fibrilação Atrial/sangue , Fibrilação Atrial/prevenção & controle , Métodos Epidemiológicos , Feminino , Hospitalização/estatística & dados numéricos , Humanos , Masculino , Pessoa de Meia-Idade , Peptídeos Natriuréticos/sangue , Prognóstico , Prevenção Secundária , Tetrazóis/uso terapêutico , Troponina T/sangue , Valina/análogos & derivados , Valina/uso terapêutico , Valsartana
2.
G Ital Cardiol ; 25(4): 453-6, 1995 Apr.
Artigo em Italiano | MEDLINE | ID: mdl-7543867

RESUMO

This presentation reports an electrocardiogram showing first degree A-V block with a very prolonged P-R interval of 0.80 sec. On several occasions an arrhythmia occurred, characterized by what looked like an A-V junctional escape rhythm with A-V dissociation. This was suggested by a variable and, at first glance, haphazard relationship between QRS complexes and P waves. Analysis of the tracing suggested that the pattern was due to an interpolated A-V junctional extrasystole, followed by a sinus beat with an inordinately long P-R interval, whose duration was 1.18 sec. This very prolonged A-V conduction time made it difficult to recognize the relationship between P waves and QRS complexes, so that the pattern appeared as an A-V dissociation.


Assuntos
Nó Atrioventricular/fisiopatologia , Complexos Cardíacos Prematuros/fisiopatologia , Bloqueio Cardíaco/fisiopatologia , Idoso , Antiarrítmicos/administração & dosagem , Fibrilação Atrial/complicações , Fibrilação Atrial/diagnóstico , Fibrilação Atrial/tratamento farmacológico , Fibrilação Atrial/fisiopatologia , Nó Atrioventricular/efeitos dos fármacos , Complexos Cardíacos Prematuros/diagnóstico , Complexos Cardíacos Prematuros/etiologia , Quimioterapia Combinada , Eletrocardiografia/efeitos dos fármacos , Eletrocardiografia/estatística & dados numéricos , Feminino , Bloqueio Cardíaco/complicações , Bloqueio Cardíaco/diagnóstico , Humanos , Quinidina/administração & dosagem , Quinidina/análogos & derivados , Fatores de Tempo , Verapamil/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA